JP4616556B2 - ポリ酒石酸エステル組成物 - Google Patents
ポリ酒石酸エステル組成物 Download PDFInfo
- Publication number
- JP4616556B2 JP4616556B2 JP2003559492A JP2003559492A JP4616556B2 JP 4616556 B2 JP4616556 B2 JP 4616556B2 JP 2003559492 A JP2003559492 A JP 2003559492A JP 2003559492 A JP2003559492 A JP 2003559492A JP 4616556 B2 JP4616556 B2 JP 4616556B2
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically active
- release
- active ingredient
- composition according
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
Description
a)有効量の薬学的有効材料をポリ酒石酸エステルポリマーと混合する段階、
b)打錠装置で混合物を成型し、10〜65kN/cm2の圧縮力を加えて圧縮錠剤を作製する段階、を含むことを特徴とする。
材料および方法:錠剤は上記と同様にして調製した。重量を計測した錠剤を、0.05%の塩化ベンザルコニウムおよび0.1%のアジ化ナトリウムを含有する12mlのリン酸塩バッファー(0.05M、pH7.4)(放出媒質)に浸漬し、37℃で4週間、インキュベートした。規定の時間に8mlの放出媒質を抜き取り、新鮮媒質を戻した。サンプルは、220nmでのUV検出を具備した逆相HPLCを使用するHPLCによってブセレリン含量を分析した。
ブセレリンまたはアザグリ−ナファレリンなど、GnRHアゴニストを投与することによって、末期卵胞生育および排卵を誘発できるLH分泌をトリガーできる。この目的を達成するためには、LH分泌が数日間継続されることが必要である。本研究の目的は、無排卵性モデルすなわち思春期前メス子ヒツジにおける末期卵胞生育および排卵を誘発するために、ブセレリンまたはアザグリ−ナファレリンを放出するポリ酒石酸エステル埋込み剤(PTA)の安全性および効力を評価することであった。
ブセレリンまたはアザグリ−ナファレリンを放出するポリ酒石酸エステル埋込み剤を、実施例1に記載した方法により調製した。46kN/cm2の圧縮力で3mmの平面パンチを使用する単発式プレスで錠剤を圧縮した。
Claims (9)
- パルス方式で薬学的有効成分を放出し、かつ27〜48kN/cm2の圧縮力で錠剤を成型することによって得られることを特徴とする、2’3’−(1’,4’−ジエチル)−L−タートリルポリ−(2,3−O−イソプロピリデン)−L−タートレートと少なくとも1種の薬学的有効成分を含む薬学的組成物。
- 前記2’3’−(1’,4’−ジエチル)−L−タートリルポリ−(2,3−O−イソプロピリデン)−L−タートレートが、40℃より高いガラス転移温度を有することを特徴とする請求項1に記載の組成物。
- 前記の薬学的有効成分が、1種または複数の抗原、抗体または薬学的成分から選択されることを特徴とする請求項1から2のいずれかに記載の組成物。
- 前記の薬学的有効成分が、GnRHアゴニストであることを特徴とする請求項3に記載の組成物。
- 前記の薬学的有効成分が、ブセレリンであることを特徴とする請求項4に記載の組成物。
- 前記の薬学的有効成分が、アザグリナファレリンであることを特徴とする請求項4に記載の組成物。
- 前記組成物が、追加的に1種または複数の薬学的に許容できる賦形剤またはアジュバントを含むことを特徴とする請求項1から6のいずれかに記載の組成物。
- a)薬学的有効成分を2’3’−(1’,4’−ジエチル)−L−タートリルポリ−(2,3−O−イソプロピリデン)−L−タートレートと混合する段階、
b)打錠装置で該混合物を成型し、27〜48kN/cm2の圧縮力を加えることにより圧縮錠剤を作製する段階、を含む請求項1から7に記載の組成物の調製方法。 - 前記の薬学的有効成分と2’3’−(1’,4’−ジエチル)−L−タートリルポリ−(2,3−O−イソプロピリデン)−L−タートレートを粉末の状態で混合することを特徴とする請求項8に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02075176 | 2002-01-16 | ||
PCT/EP2003/000514 WO2003059329A2 (en) | 2002-01-16 | 2003-01-15 | Polytartrate composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005516966A JP2005516966A (ja) | 2005-06-09 |
JP4616556B2 true JP4616556B2 (ja) | 2011-01-19 |
Family
ID=8185536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003559492A Expired - Fee Related JP4616556B2 (ja) | 2002-01-16 | 2003-01-15 | ポリ酒石酸エステル組成物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050118271A1 (ja) |
EP (1) | EP1467716A2 (ja) |
JP (1) | JP4616556B2 (ja) |
AR (1) | AR038145A1 (ja) |
AU (1) | AU2003235708A1 (ja) |
CA (1) | CA2471483A1 (ja) |
WO (1) | WO2003059329A2 (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070281003A1 (en) * | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
CN102283698B (zh) * | 2006-06-12 | 2016-02-24 | 史密夫和内修有限公司 | 用于进行胫骨切除的引导装置 |
PL2037914T3 (pl) | 2006-06-14 | 2014-04-30 | Intervet Int Bv | Zawiesina zawierająca karbaminian benzoimidazolu i polisorbat |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
EP2968162B1 (en) * | 2013-03-15 | 2020-12-02 | Incube Labs, Llc | Multi-stage biodegradable drug delivery platform |
EP3177319A1 (en) * | 2014-08-04 | 2017-06-14 | Janssen Sciences Ireland UC | Compacted solid dosage form |
BR112018072539A2 (pt) | 2016-05-05 | 2019-03-26 | Aquestive Therapeutics, Inc. | composições de epinefrina de administração aumentada |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3936191C2 (de) * | 1989-10-31 | 1996-10-17 | Boehringer Ingelheim Kg | Neue Copolymere aus Milchsäure und Weinsäure, ihre Herstellung sowie ihre Verwendung |
EP0514790A2 (de) * | 1991-05-24 | 1992-11-25 | Hoechst Aktiengesellschaft | Polykondensate, die Weinsäurederivate enthalten, Verfahren zu ihrer Herstellung und Verwendung derselben |
US5838571A (en) * | 1996-01-29 | 1998-11-17 | Alza Corporation | Tablet press monitoring and controlling method and apparatus |
CA2250908C (en) * | 1996-04-30 | 2012-03-13 | Takeda Chemical Industries, Ltd. | Combined use of gnrh agonist and antagonist |
IL145106A0 (en) * | 2000-08-30 | 2002-06-30 | Pfizer Prod Inc | Intermittent administration of a geowth hormone secretagogue |
-
2003
- 2003-01-15 US US10/501,284 patent/US20050118271A1/en not_active Abandoned
- 2003-01-15 WO PCT/EP2003/000514 patent/WO2003059329A2/en active Application Filing
- 2003-01-15 AU AU2003235708A patent/AU2003235708A1/en not_active Abandoned
- 2003-01-15 EP EP03729488A patent/EP1467716A2/en not_active Withdrawn
- 2003-01-15 AR ARP030100102A patent/AR038145A1/es unknown
- 2003-01-15 CA CA002471483A patent/CA2471483A1/en not_active Abandoned
- 2003-01-15 JP JP2003559492A patent/JP4616556B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2003235708A1 (en) | 2003-07-30 |
US20050118271A1 (en) | 2005-06-02 |
WO2003059329A3 (en) | 2003-12-18 |
AR038145A1 (es) | 2004-12-29 |
JP2005516966A (ja) | 2005-06-09 |
EP1467716A2 (en) | 2004-10-20 |
CA2471483A1 (en) | 2003-07-24 |
WO2003059329A2 (en) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4616556B2 (ja) | ポリ酒石酸エステル組成物 | |
Winzenburg et al. | Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems | |
US5916584A (en) | Controlled release container with core and outer shell | |
EP0576522B1 (en) | A single dose vaccination system | |
JP2003517014A (ja) | 即放性および徐放性成分を含有する医薬インプラントおよび投与方法 | |
EP0139286A2 (en) | Prolonged sustained-release preparations | |
CA2452075C (en) | Sustained release delivery system | |
US7999005B2 (en) | Growth stimulant compositions | |
US20110142901A1 (en) | Sustained release composition | |
JP2004535473A5 (ja) | ||
JP2005517653A (ja) | X線不透過性徐放性医薬器具 | |
CN1145496C (zh) | 用于肽释放的新型组合物 | |
JP2851390B2 (ja) | 間欠放出性剤形 | |
JP2005505513A (ja) | 寄生虫病の治療 | |
Bermudez et al. | Challenges and opportunities in polymer technology applied to veterinary medicine | |
US8414947B2 (en) | Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter | |
CA2348841C (en) | Improved growth stimulant compositions | |
AU710749B2 (en) | Controlled release container with core and outer shell | |
JPH06507155A (ja) | 単一ドーズ予防接種システム | |
Schliecker et al. | Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems | |
AP105A (en) | Treatment of animals. | |
Schliecker et al. | Poly (2, 3-(1, 4-diethyl tartrate)-co-2, 3-isopropyliden tartrate): a polymer for pulsatile release systems? | |
JPH01500899A (ja) | 生物適合性インプラント |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060111 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20061222 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090825 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20091118 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20091126 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100223 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100706 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100907 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101005 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101022 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131029 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |